PTPN3 and ovarian carcinoma: Soft agar colony formation assays showed that stable silencing of PTPN3 significantly inhibited the colony forming ability of both cisplatin and doxorubicin resistant ovarian cancer cells, suggesting that stable silencing of PTPN3 inhibits cellular anchorage-independent growth of resistant ovarian cancer cells in vitro (Fig. 4A,B).